M. Lester

发表

Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspension in Syrspend® SF PH4

P. Rault, P. Boivin, Anne-Claire Bonnaure, 2018 .

PP-054 Stability study of 100 mg/ml paediatric pyrazinamide oral suspension in syrspend

M. Lester, C. Tron, C. Geffroy, 2017 .

Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing

A. Mantalaris, E. Tsiridis, M. Heliotis, 2009, Expert opinion on investigational drugs.

InvestigatingtheroleofPDGFas apotentialdrugtherapyinbone formationandfracturehealing

A. Mantalaris, E. Tsiridis, M. Heliotis, 2009 .

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study

E. Leray, G. Edan, V. Deburghgraeve, 2015, Journal of Neurology.

PP-028 Stability study of 1 mg/ml paediatric warfarin oral suspension in syrspend

M. Lester, P. Boivin, I. Perović, 2017 .

Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)

Pho V. Le, P. Boivin, M. Lester, 2022, Pharmaceutical Technology in Hospital Pharmacy.

Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study

G. Guillerm, A. Kouatchet, L. Bodénes, 2023, Annals of Hematology.

Physicochemical stability of compounded midazolam capsules over a one-year storage period

P. Boivin, Anne-Claire Bonnaure, M. Lester, 2020 .

Stability of 5 mg/mL Nitrendipine Oral Suspension in Syrspend® SF PH4

P. Rault, P. Boivin, Anne-Claire Bonnaure, 2018 .

Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma.

R. Houot, P. Delépine, R. Le Calloch, 2023, Leukemia & lymphoma.